These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5429054)

  • 21. Acetylcholinesterase inhibitors: synthesis and structure-activity relationships of omega-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl derivatives.
    Rampa A; Bisi A; Valenti P; Recanatini M; Cavalli A; Andrisano V; Cavrini V; Fin L; Buriani A; Giusti P
    J Med Chem; 1998 Oct; 41(21):3976-86. PubMed ID: 9767635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Miotic effect of a new anticholinesterase agent (bismthylpyridyl hexamethylene bromide of methyl carbamic acid)].
    Bonomi L; Polito D
    Minerva Oftalmol; 1969; 11(3):77-81. PubMed ID: 5406012
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition.
    Verheijen JC; Wiig KA; Du S; Connors SL; Martin AN; Ferreira JP; Slepnev VI; Kochendörfer U
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3243-6. PubMed ID: 19423342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microcalorimetric study of the inhibition of butyrylcholinesterase by carbamates.
    Debord J; Laubarie C; Dantoine T
    Anal Biochem; 2008 Feb; 373(2):247-52. PubMed ID: 17950687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antagonistic effects of cholinergic drugs on xylazine induced sedation].
    Ding RG; Huang SJ; Yang JS
    Yao Xue Xue Bao; 1993; 28(3):172-6. PubMed ID: 8368075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
    Lin MC; Hwang MT; Chang HG; Lin CS; Lin G
    J Biochem Mol Toxicol; 2007; 21(6):348-53. PubMed ID: 17994573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A quantitative structure-activity study of anticonvulsant benzyl N,N-dimethylcarbamates.
    Yamagami C; Sonoda C; Takao N; Tanaka M; Yamada J; Horisaka K; Fujita T
    Chem Pharm Bull (Tokyo); 1982 Nov; 30(11):4175-80. PubMed ID: 7165882
    [No Abstract]   [Full Text] [Related]  

  • 28. [Synthesis and pharmacological study of various N,N-dialkylarylamine dicarbamates].
    Iorio MA; Marotta M; Michalek H
    Farmaco Sci; 1968 Sep; 23(9):842-58. PubMed ID: 5713118
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurotoxicity of the pesticidal carbamates.
    Miller DB
    Neurobehav Toxicol Teratol; 1982; 4(6):779-87. PubMed ID: 6763154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
    Lin G; Lee YR; Liu YC; Wu YG
    Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of cholinesterase from different sources by 3-diethylaminophenyl-N-methylcarbamate methiodide in vitro.
    Bajgar J; Patocka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(5):597-602. PubMed ID: 6599176
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
    Crismon ML
    Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.
    Darvesh S; Darvesh KV; McDonald RS; Mataija D; Walsh R; Mothana S; Lockridge O; Martin E
    J Med Chem; 2008 Jul; 51(14):4200-12. PubMed ID: 18570368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors.
    Carolan CG; Dillon GP; Gaynor JM; Reidy S; Ryder SA; Khan D; Marquez JF; Gilmer JF
    J Med Chem; 2008 Oct; 51(20):6400-9. PubMed ID: 18817366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Aminostigmine as a cholinesterase inhibitor and as an agent for treating poisonings by cholinergic blockers].
    Prozorovskiĭ VB; Livanov GA; Velikova VD; Afanas'ev VV; Pavlova LV
    Eksp Klin Farmakol; 1994; 57(5):13-5. PubMed ID: 7696893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syntheses and anticholinesterase activities of (3aS)-N1, N8-bisnorphenserine, (3aS)-N1,N8-bisnorphysostigmine, their antipodal isomers, and other potential metabolites of phenserine.
    Yu Q; Greig NH; Holloway HW; Brossi A
    J Med Chem; 1998 Jun; 41(13):2371-9. PubMed ID: 9632370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acylphenols from Myristica crassa as new acetylcholinesterase inhibitors.
    Maia A; Schmitz-Afonso I; Martin MT; Awang K; Laprévote O; Guéritte F; Litaudon M
    Planta Med; 2008 Oct; 74(12):1457-62. PubMed ID: 18671198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of action of Alzheimer medications].
    Alhainen K
    Duodecim; 2003; 119(20):1959-66. PubMed ID: 14640001
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of glabridin from Glycyrrhiza glabra on learning and memory in mice.
    Cui YM; Ao MZ; Li W; Yu LJ
    Planta Med; 2008 Mar; 74(4):377-80. PubMed ID: 18484526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A tryptophan in the bottleneck of the catalytic gorge of an invertebrate acetylcholinesterase confers relative resistance to carbamate and organophosphate inhibitors.
    Patel R; Sanders R; Brown L; Baker S; Tsigelny I; Pezzementi L
    Cell Biochem Biophys; 2006; 46(3):253-64. PubMed ID: 17272851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.